Lane S - Search Results

1

Remdesivir in Treatment of COVID-19: A Systematic Benefit-Risk Assessment.

Davies M, Osborne V, Lane S, Roy D, Dhanda S, Evans A, Shakir S. Davies M, et al. Among authors: lane s. Drug Saf. 2020 Jul;43(7):645-656. doi: 10.1007/s40264-020-00952-1. Drug Saf. 2020. PMID: 32468196 Free PMC article.

2

Investigation assessing the publicly available evidence supporting postmarketing withdrawals, revocations and suspensions of marketing authorisations in the EU since 2012.

Lane S, Lynn E, Shakir S. Lane S, et al. BMJ Open. 2018 Jan 23;8(1):e019759. doi: 10.1136/bmjopen-2017-019759. BMJ Open. 2018. PMID: 29362275 Free PMC article.

3

Lopinavir-Ritonavir in the Treatment of COVID-19: A Dynamic Systematic Benefit-Risk Assessment.

Osborne V, Davies M, Lane S, Evans A, Denyer J, Dhanda S, Roy D, Shakir S. Osborne V, et al. Among authors: lane s. Drug Saf. 2020 Aug;43(8):809-821. doi: 10.1007/s40264-020-00966-9. Drug Saf. 2020. PMID: 32578156 Free PMC article.

4

How to Investigate a Serious Adverse Event Reported During a Clinical Trial for a COVID-19 Vaccine.

Shakir S, Lane S, Davies M. Shakir S, et al. Among authors: lane s. Drug Saf. 2021 Jan;44(1):1-5. doi: 10.1007/s40264-020-01018-y. Epub 2020 Nov 21. Drug Saf. 2021. PMID: 33219926 Free PMC article. No abstract available.

5

The Role of the Contextual Cohort to Resolve Some Challenges and Limitations of Comparisons in Pharmacoepidemiology.

Osborne V, Lane S, Shakir SAW. Osborne V, et al. Among authors: lane s. Drug Saf. 2021 Aug;44(8):835-841. doi: 10.1007/s40264-021-01074-y. Epub 2021 May 7. Drug Saf. 2021. PMID: 33961212 Free PMC article.

6

Reports of myocarditis and pericarditis following mRNA COVID-19 vaccination: a systematic review of spontaneously reported data from the UK, Europe and the USA and of the scientific literature.

Lane S, Yeomans A, Shakir S. Lane S, et al. BMJ Open. 2022 May 25;12(5):e059223. doi: 10.1136/bmjopen-2021-059223. BMJ Open. 2022. PMID: 35613761 Free PMC article.

7

Systematic review of spontaneous reports of myocarditis and pericarditis in transplant recipients and immunocompromised patients following COVID-19 mRNA vaccination.

Lane S, Yeomans A, Shakir S. Lane S, et al. BMJ Open. 2022 Jul 1;12(7):e060425. doi: 10.1136/bmjopen-2021-060425. BMJ Open. 2022. PMID: 35777878 Free PMC article.

8

Assessing Case Fatality on Cases of Thrombosis with Concurrent Thrombocytopenia Following COVID-19 Vaccine AstraZeneca (Vaxzevria) in the United Kingdom: A Review of Spontaneously Reported Data.

Lane S, Shakir S. Lane S, et al. Drug Saf. 2022 Sep;45(9):1003-1008. doi: 10.1007/s40264-022-01217-9. Epub 2022 Aug 4. Drug Saf. 2022. PMID: 35927605 Free PMC article. Review.

9

Correction to: Assessing Case Fatality on Cases of Thrombosis with Concurrent Thrombocytopenia Following COVID-19 Vaccine AstraZeneca (Vaxzevria) in the United Kingdom: A Review of Spontaneously Reported Data.

Lane S, Shakir S. Lane S, et al. Drug Saf. 2022 Nov;45(11):1439-1440. doi: 10.1007/s40264-022-01233-9. Drug Saf. 2022. PMID: 36057085 Free PMC article. No abstract available.

10

The International Working Group on New Developments in Pharmacovigilance: Advancing Methods and Communication in Pharmacovigilance.

Cooper D, Platt RW, van Hunsel F, Davies M, Yeomans A, Lane S, Shakir S. Cooper D, et al. Among authors: lane s. Clin Ther. 2024 Jul;46(7):565-569. doi: 10.1016/j.clinthera.2023.12.008. Epub 2024 Jan 16. Clin Ther. 2024. PMID: 38233256 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,697 results

Search Page

Filters